arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2405.20765physics.med-phphysics.bio-phphysics.optics
收藏

一种基于快速高密度光谱扫描的可运输式高光谱成像系统,用于术中定量生物化学映射的新鲜组织活检

A transportable hyperspectral imaging setup based on fast, high-density spectral scanning for in situ quantitative biochemical mapping of fresh tissue biopsies

University of Florence(佛罗伦萨大学);European Laboratory for Non-Linear Spectroscopy(欧洲非线性光谱学实验室);Technical University of Munich(慕尼黑工业大学);Azienda Ospedaliero-Universitaria Careggi, University of Florence(卡雷吉大学医院,佛罗伦萨大学);University College London(伦敦大学学院);Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220(里昂大学,里昂国立应用科学学院,克洛德·贝尔纳里昂大学,圣艾蒂安大学,法国国家科学研究中心,法国国家健康与医学研究院,CREATIS联合研究单位5220);Imperial College London(帝国理工学院);National Research Council, National Institute of Optics(国家研究委员会,光学国家研究所)
Luca Giannoni, Marta Marradi, Kevin Scibilia, Ivan Ezhov, Camilla Bonaudo, Angelos Artemiou, Anam Toaha, Frederic Lange, Charly Caredda, Bruno Montcel, Alessand… 展开作者

Luca Giannoni, Marta Marradi, Kevin Scibilia, Ivan Ezhov, Camilla Bonaudo, Angelos Artemiou, Anam Toaha, Frederic Lange, Charly Caredda, Bruno Montcel, Alessandro Della Puppa, Ilias Tachtsidis, Daniel Ruckert, Francesco Saverio Pavone

AI总结:

HyperProbe1是一种可运输式高光谱成像系统,用于术中快速生化分析和映射新鲜组织活检,无需固定或染色,可实现快速、非破坏性的定量生物化学映射。

摘要:

手术活检(如胶质瘤和胶质母细胞瘤切除)的病理学检查在当前临床实践中受到实验室分析和病理筛查所需时间长的限制,通常需要几天甚至几周才能完成。我们提出了一种可运输、高密度、基于光谱扫描的高光谱成像系统,称为HyperProbe1,该系统可以在切除后立即对新鲜手术组织样本进行现场快速生化分析和映射,无需固定或染色。HyperProbe1基于超连续谱激光照明结合声光可调滤光器进行光谱扫描。这种技术允许用户在可见光和近红外范围内(510至900纳米)选择任意数量和类型的波长带(最多79个),并重建由高分辨率宽场图像组成的3D超立方体,其中每个像素都关联一个完整的光谱。该系统应用于11例常规患者的胶质瘤新鲜手术活检,包括不同等级的肿瘤分类。通过快速光谱解混对组织成分进行定量分析,以重建主要生物标志物的映射。我们还尝试通过样本组成差异推断肿瘤分类,表明可以利用脂质含量和差异细胞色素c氧化酶浓度来区分低级和高级胶质瘤。HyperProbe1对术中定量生物化学映射的性能进行了概念验证,为通过非破坏性、现场快速筛查新鲜组织样本来改进当前术后病理学实践铺平了道路,这种筛查可在切除后几分钟内完成。

英文摘要:

Histopathological examination of surgical biopsies, such as in glioma and glioblastoma resection, is hindered in current clinical practice by the long times required for the laboratory analysis and pathological screening, typically taking several days or even weeks to be completed. We propose here a transportable, high-density, spectral-scanning based hyperspectral imaging setup, named HyperProbe1, that can provide in situ, fast biochemical analysis and mapping of fresh surgical tissue samples, right after excision, and without the need of fixing or staining. HyperProbe1 is based on spectral scanning via supercontinuum laser illumination filtered with acousto-optic tuneable filters. Such methodology allows the user to select any number and type of wavelength bands in the visible and near-infrared range between 510 and 900 nm (up to 79), and to reconstruct 3D hypercubes composed of high-resolution, widefield images of the surgical samples, where each pixel is associated with a complete spectrum. The system is applied on 11 fresh surgical biopsies of glioma from routine patients, including different grades of tumour classification. Quantitative analysis of the composition of the tissue is performed via fast spectral unmixing to reconstruct mapping of major biomarkers. We also provided a preliminary attempt to infer tumour classification based on differences of composition in the samples, suggesting the possibility to use lipid content and differential cytochrome-c-oxidase concentrations to distinguish between lower and higher grade gliomas. A proof-of-concept of the performances of HyperProbe1 for quantitative, biochemical mapping of surgical biopsies is demonstrated, paving the way for improving current post-surgical, histopathological practice via non-destructive, in situ streamlined screening of fresh tissue samples in a matter of minutes after excision.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑